CC BY 4.0 · Rev Bras Ginecol Obstet 2021; 43(11): 834-839
DOI: 10.1055/s-0041-1739464
Original Article
Infertility

Association of Overweight and Consistent Anovulation among Infertile Women with Regular Menstrual Cycle: A Case-control Study

Associação entre sobrepeso e anovulação consistente em mulheres inférteis com ciclo menstrual regular: Um estudo de caso-controle
1   Unidade Acadêmica de Ciências da Saúde, Universidade Federal de Jataí, Jataí, GO, Brazil
,
1   Unidade Acadêmica de Ciências da Saúde, Universidade Federal de Jataí, Jataí, GO, Brazil
,
2   Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina, Hospital das Clínicas, Laboratório de Reprodução Humana, Universidade Federal de Goiás, Goiânia, GO, Brazil
,
2   Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina, Hospital das Clínicas, Laboratório de Reprodução Humana, Universidade Federal de Goiás, Goiânia, GO, Brazil
› Author Affiliations

Abstract

Objective It has been suggested that excess body weight could represent a risk factor for infertility outcomes. The present study aimed to evaluate the association of overweight and anovulation among infertile women with regular menstrual cycles.

Methods We conducted a retrospective case-control study with consistently anovulatory patients undergoing assisted reproduction treatment. The patients were stratified into normal weight (body mass index [BMI]: 18.5–24.9kg/m2) and overweight (BMI: 25.0–29.9kg/m2).Those with polycystic ovary syndrome or obesity were excluded. The groups were matched for age, duration of infertility, prolactin, follicle stimulating hormone (FSH), thydroid stimulating hormone (TSH), luteinizing hormone (LH), and estradiol levels.

Results Overweight was significantly associated with anovulation, when using the World Health Organization (WHO) criteria for anovulation: progesterone levels > 5.65 ng/ml and ultrasonography evidence of follicle collapse (odds ratio [OR]: 2.69; 95% confidence interval [CI95%]: 1.04–6.98).

Conclusion Body mass index above the normal range jeopardizes ovulation among non-obese infertile women with regular menstrual cycles.

Resumo

Objetivo O excesso de peso corporal tem sido associado como fator de risco para infertilidade. Este estudo teve como objetivo avaliar a associação de sobrepeso e anovulação entre mulheres inférteis com ciclos menstruais regulares.

Métodos Realizamos um estudo retrospectivo de caso-controle com mulheres com anovulação consistente em tratamento por reprodução assistida. As pacientes foram estratificadas entre aquelas com peso normal (índice de massa corporal [IMC]: 18,5–24,9 Kg/m2) e as com sobrepeso (IMC: 25,0–29,9 Kg/m2). As pacientes com síndrome do ovário policístico ou obesidade foram excluídas. Os grupos foram pareados por idade, duração da infertilidade, níveis de prolactina, hormônio folículo-estimulante (FSH), hormônio tiroestimulante (TSH), hormônio luteinizante (LH) e estradiol.

Resultados O excesso de peso associou-se significativamente à anovulaçãoquando usados os critérios de anovulação da Organização Mundial de Saúde (OMS): níveis de progesterona > 5,65 ng/ml e evidência ultrassonográfica de colapso folicular (razão de chances [RC]: 2,69; IC95%: 1,04–6,98).

Conclusão O IMC acima da faixa normal compromete a ovulação em mulheres inférteis não obesas com ciclos menstruais regulares.

Contributions

C. R. G. contributed in the study design, data analysis and manuscript writing; E. G. M. S. contributed in the study design and data analysis; Y.A.R.L. contributed in the study design and data analysis; M. S. A. contributed in the study design, data analysis, and interpretation and manuscript writing. All authors have seen, reviewed, and approved the final version of the manuscript.




Publication History

Received: 03 December 2019

Accepted: 03 September 2021

Article published online:
06 December 2021

© 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Hensrud DD, Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc 2006; 81 (10, Suppl) S5-S10
  • 2 Love JG, McKenzie JS, Nikokavoura EA, Broom J, Rolland C, Johnston KL. The experiences of women with polycystic ovary syndrome on a very low-calorie diet. Int J Womens Health 2016; 8: 299-310
  • 3 Kuchenbecker WK, Groen H, Zijlstra TM, Bolster JH, Slart RH, van der Jagt EJ. et al. The subcutaneous abdominal fat and not the intraabdominal fat compartment is associated with anovulation in women with obesity and infertility. J Clin Endocrinol Metab 2010; 95 (05) 2107-2112
  • 4 Hollmann M, Runnebaum B, Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod 1996; 11 (09) 1884-1891
  • 5 Buck GM, Sever LE, Batt RE, Mendola P. Life-style factors and female infertility. Epidemiology 1997; 8 (04) 435-441
  • 6 Loret de Mola JR. Obesity and its relationship to infertility in men and women. Obstet Gynecol Clin North Am 2009; 36 (02) 333-346 , ix
  • 7 Sadia S, Waqar F, Akhtar T, Sultana S. Characteristics of infertile patients with ovulatory dysfunction and their relation to body mass index. J Ayub Med Coll Abbottabad 2009; 21 (03) 12-16
  • 8 Weiss RV, Clapauch R. Female infertility of endocrine origin. Arq Bras Endocrinol Metabol 2014; 58 (02) 144-152
  • 9 Parihar M. Obesity and infertility. Rev Gynaecol Pract 2003; 3 (03) 120-126
  • 10 Zain MM, Norman RJ. Impact of obesity on female fertility and fertility treatment. Womens Health (Lond) 2008; 4 (02) 183-194
  • 11 Tamer Erel C, Senturk LM. The impact of body mass index on assisted reproduction. Curr Opin Obstet Gynecol 2009; 21 (03) 228-235
  • 12 Chavarro JE, Ehrlich S, Colaci DS, Wright DL, Toth TL, Petrozza JC. et al. Body mass index and short-term weight change in relation to treatment outcomes in women undergoing assisted reproduction. Fertil Steril 2012; 98 (01) 109-116
  • 13 Lashen H, Ledger W, Bernal AL, Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod 1999; 14 (03) 712-715
  • 14 Maheshwari A. Overweight and obesity in infertility: cost and consequences. Hum Reprod Update 2010; 16 (03) 229-230
  • 15 Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril 2015; 103 (06) e44-e50
  • 16 Nelson SM, Fleming RF. The preconceptual contraception paradigm: obesity and infertility. Hum Reprod 2007; 22 (04) 912-915
  • 17 Bongain A, Isnard V, Gillet JY. Obesity in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol 1998; 77 (02) 217-228
  • 18 Dravecka I, Lazurova I, Kraus V. Obesity is the major factor determining an insulin sensitivity and androgen production in women with anovulary cycles. Bratisl Lek Listy 2003; 104 (12) 393-399
  • 19 Lash MM, Armstrong A. Impact of obesity on women's health. Fertil Steril 2009; 91 (05) 1712-1716
  • 20 Rowe PJ, Comhaire FH, Hargreave TB, Mellows HJ. World Health Organization. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press; 1993